Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „formulations“
Suchtreffer
Begriffe & Kennungen
Agilus · 4.8 · The adverse reactions observed are linked to dantrolene and its formulations for acute, intravenous use and fo
Eintrag öffnenAlkindi · 4.8 · When changing a patient from other oral hydrocortisone formulations to Alkindi, inaccuracy in the dosing possi
Eintrag öffnenByannli (previously Paliperidone Janssen-Cilag International) · 4.8 · Undesirable effects noted with risperidone formulations
Eintrag öffnenColobreathe · 4.5 · Caution should be taken with concomitant use with other formulations of colistimethate sodium as there is litt
Eintrag öffnenDarzalex · 4.5 · Clinical pharmacokinetic assessments with daratumumab intravenous or subcutaneous formulations and lenalidomid
Eintrag öffnenDepotpräparate
Eintrag öffnenFormeldiät
Eintrag öffnenForschungsdesign
Eintrag öffnenGanfort · 4.8 · Table 1: List of adverse reactions with all GANFORT formulations (multi-dose and single-dose)
Eintrag öffnenGanfort · 4.8 · Table 1: List of adverse reactions with all GANFORT formulations (multi-dose and single-dose)
Eintrag öffnenHyQvia · 4.8 · The most frequent adverse reactions reported during post-marketing use of rHuPH20 in similar formulations admi
Eintrag öffnenINOmax · 4.5 · 18 REG-15307/v.43 Page 18/56 oral, parenteral, or topical formulations may cause methaemoglobinaemia. Care mus
Eintrag öffnenInvega · 4.8 · Undesirable effects noted with risperidone formulations Paliperidone is the active metabolite of risperidone,
Eintrag öffnenIvemend · 4.8 · Summary of the safety profile In clinical studies, various formulations of fosaprepitant have been administere
Eintrag öffnenLysodren · 4.5 · Fat-rich food: Data with various mitotane formulations suggest that administration with fat-rich food enhances
Eintrag öffnenMissbrauch-abschreckende Formulierungen
Eintrag öffnenRevolade · 4.5 · The administration of eltrombopag tablet or powder for oral suspension formulations with a high- calcium meal
Eintrag öffnenRevolade · 4.5 · The administration of eltrombopag tablet or powder for oral suspension formulations with a high- calcium meal
Eintrag öffnenRybrevant · 4.8 · Clinically relevant differences between the intravenous and subcutaneous formulations, when given in combinati
Eintrag öffnenRybrevant · 4.8 · In the dataset of Rybrevant (either intravenous or subcutaneous formulations) in combination with lazertinib (
Eintrag öffnen